Detailed information for compound 1506201

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 344.402 | Formula: C20H24O5
  • H donors: 1 H acceptors: 2 LogP: 4.97 Rotable bonds: 8
    Rule of 5 violations (Lipinski): 1
  • SMILES: COc1cc(OC)cc(c1/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C)OC
  • InChi: 1S/C20H24O5/c1-14(7-6-8-15(2)11-20(21)22)9-10-17-18(24-4)12-16(23-3)13-19(17)25-5/h6-13H,1-5H3,(H,21,22)/b8-6+,10-9+,14-7+,15-11+
  • InChiKey: QOERSILUVNMDPG-PIKGMIDQSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Mycobacterium tuberculosis Probable bifunctional membrane-associated penicillin-binding protein 1A/1B PonA2 (murein polymerase) [includes: penicillin-insen 0.2691 0.2124 1
Wolbachia endosymbiont of Brugia malayi cell division protein FtsI 0.1407 0.054 0.5
Mycobacterium ulcerans bifunctional membrane-associated penicillin-binding protein 1A/1B PonA2 0.2691 0.2124 0.2124
Mycobacterium leprae POSSIBLE PENICILLIN-BINDING LIPOPROTEIN 0.1396 0.0527 0.069
Mycobacterium ulcerans bifunctional penicillin-binding protein 1A/1B PonA1 0.4792 0.4717 0.4717
Mycobacterium leprae PROBABLE BIFUNCTIONAL PENICILLIN-BINDING PROTEIN 1A/1B PONA1 (MUREIN POLYMERASE) (PBP1): PENICILLIN-INSENSITIVE TRANSGLYCOSYLASE 0.4792 0.4717 1
Treponema pallidum penicillin-binding protein (pbp-2) 0.4792 0.4717 1
Treponema pallidum penicillin-binding protein (pbp-1) 0.1407 0.054 0.1145
Mycobacterium tuberculosis Possible penicillin-binding protein 0.1489 0.0642 0.223
Mycobacterium ulcerans penicillin-binding lipoprotein 0.1396 0.0527 0.0527
Mycobacterium tuberculosis Class a beta-lactamase BlaC 0.1234 0.0327 0.0583
Mycobacterium leprae PROBABLE BIFUNCTIONAL MEMBRANE-ASSOCIATED PENICILLIN-BINDING PROTEIN 1A/1B PONA2 (MUREIN POLYMERASE) [INCLUDES: PENICILLIN-INSEN 0.2691 0.2124 0.424
Mycobacterium ulcerans penicillin-binding protein PbpA 0.1144 0.0216 0.0216
Mycobacterium tuberculosis Possible penicillin-binding lipoprotein 0.1396 0.0527 0.1628
Mycobacterium ulcerans class a beta-lactamase, BlaC 0.1234 0.0327 0.0327
Trichomonas vaginalis conserved hypothetical protein 0.4792 0.4717 0.5
Mycobacterium tuberculosis Probable bifunctional penicillin-binding protein 1A/1B PonA1 (murein polymerase) (PBP1): penicillin-insensitive transglycosylase 0.2101 0.1397 0.6188

Activities

Activity type Activity value Assay description Source Reference
Activity (functional) Activation of Akt in human MCF7 cells expressing estrogen receptor at 10'-5 M after 4 hrs by Western blotting ChEMBL. 21208698
Activity (functional) Activation of Akt in human MCF7 cells expressing estrogen receptor at 10'-5 M after 9 hrs by Western blotting ChEMBL. 21208698
Inhibition (functional) = -53 % Antiproliferative activity against human MCF7 cells expressing estrogen receptor assessed as cell growth inhibition 50 uM after 72 hrs by WST-1 assay relative to control ChEMBL. 21208698
Inhibition (functional) = 52 % Antiproliferative activity against human MCF7 cells expressing estrogen receptor at 10 uM after 72 hrs by WST-1 assay ChEMBL. 21208698

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.